文献速递妇科

门诊子宫内膜活检失败的危险因素:门诊子宫内膜活检(Pipelle)与诊断性刮宫的对比研究

Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage.
PubMed 文献 · J Minim Invasive Gynecol · 2017-12-06

单中心前瞻性研究纳入466例有子宫内膜活检指征的患者,均先接受Pipelle活检再行诊断性刮宫,组织分别送病理。Pipelle操作失败10/466例(2.146%),样本不足5.921%(27/456),病理诊断不一致14.254%(65/456)。宫颈手术史、宫腔操作史、宫颈口针尖样与操作失败相关;子宫体积<43 cm3、超声子宫内膜不均与样本不足相关。

要点

  • Pipelle操作失败率为2.146%(10/466),样本不足率为5.921%(27/456),病理诊断不一致率为14.254%(65/456)。
  • 宫颈手术史(OR 26.510)、宫腔操作史(OR 0.096)、宫颈口针尖样(OR 5.939)与Pipelle操作失败显著相关。
  • Pipelle检出全部子宫内膜癌病例,但子宫内膜不典型增生仅检出50.000%(7/14),子宫内膜息肉仅检出26.471%(9/34)。

核心结论

  • Pipelle虽是子宫内膜活检的一线方法,但在本研究报告的危险因素人群中可能失败,选择Pipelle时需更多考量。

研究设计与样本

  • 单中心前瞻性研究(加拿大任务组分类II),纳入466例有子宫内膜活检指征的患者,均先接受Pipelle活检再行诊断性刮宫,样本分别送组织病理学诊断。

主要发现

  • Pipelle操作在466例中失败10例(2.146%)。
  • Pipelle总体样本不足率为5.921%(27/456),组织病理学诊断不一致率为14.254%(65/456)。
  • 多变量分析显示宫颈手术史(OR 26.510;95%CI 2.932-239.784;p=.004)、既往宫腔操作史(OR 0.096;95%CI 0.017-0.554;p=.009)、宫颈口针尖样(OR 5.939;95%CI 1.134-31.108;p=.035)与Pipelle操作失败显著相关。
  • 子宫体积<43 cm3(OR 8.229;95%CI 1.902-35.601;p=.005)与超声发现的子宫内膜不均(OR 0.176;95%CI 0.042-0.734;p=.017)与样本不足显著相关。
  • Pipelle检出全部子宫内膜癌病例,而子宫内膜不典型增生仅检出50.000%(7/14)、息肉仅检出26.471%(9/34)、息肉伴子宫内膜增生无不典型仅检出18.182%(2/11)。

临床怎么用

  • 作者认为,Pipelle虽是子宫内膜活检的一线方法,但在本研究报告的危险因素人群中可能失败,选择Pipelle时需更多考量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine the risk factors for Pipelle diagnostic failure, which might help healthcare providers choose the appropriate protocol for endometrial evaluation individually. DESIGN: A single-center prospective study (Canadian Task Force classification II). SETTING: The Obstetrics and Gynecology Hospital of Fudan University. PATIENTS: Patients (n = 466) with an indication for endometrial biopsy. INTERVENTIONS: All patients received Pipelle and then diagnostic dilation and curettage. The samples were sent for histopathologic diagnosis separately. MEASUREMENTS AND MAIN RESULTS: The Pipelle procedure failed in 10 of 466 patients (2.146%). The general sample inadequacy and histopathologic diagnosis inconsistency of Pipelle was 5.921% (27/456) and 14.254% (65/456), respectively. Upon multivariate analysis, history of cervical operation(s) (odds ratio [OR], 26.510; 95% coefficient interval [CI], 2.932-239.784; p = .004), prior intrauterine procedure(s) (OR, .096; 95% CI, .017-.554; p = .009), and pinpoint cervical os (OR, 5.939; 95% CI, 1.134-31.108; p = .035) were significantly associated with Pipelle procedure failure. Meanwhile, uterine volume < 43 cm3 (OR, 8.229; 95% CI, 1.902-35.601; p = .005) and uneven endometrium detected by ultrasound (OR, .176; 95% CI, .042-.734; p = .017) had significant correlation with sample inadequacy. Pipelle detected all endometrial cancer cases, whereas only 50.000% (7/14) of endometrial hyperplasia with atypia, 26.471% (9/34) of polyps, and 18.182% (2/11) of polyps with endometrial hyperplasia without atypia cases were detected by Pipelle. CONCLUSION: Although Pipelle is the first-line method for endometrial biopsy, it might fail in women with risk factors identified in this study. More considerations should be taken when choosing Pipelle.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Xie B, Qian C, Yang B, et al. Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage. J Minim Invasive Gynecol. 2017. PMID: 29223698. doi:10.1016/j.jmig.2017.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。